Steroide fördern Brustkrebs

  • K. Münstedt
  • R. von Georgi
Conference paper

Zusammenfassung

  1. 1.

    Der ursächliche Einfluss der Steroide im Rahmen des Mammakarzinoms bleibt unklar.

     
  2. 2.

    Seit einiger Zeit werden Polymorphismen im Zytochrom P450 und die damit verbundenen Veränderungen des Steroidstoffwechsels verdächtig. Diese spielen im Prozess der Tumorinitation und -promotion eine wichtige Rolle.

     
  3. 3.

    Die entstehenden Metabolite sind möglicherweise auch in den Prozess der Karzinogenese involviert.

     

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bastert G (1990) Malignome der Mamma. In: Schmidt-Mathiesen H (Hrsg) Klinik der Frauenheilkunde und Geburtshilfe, vol 12. Spezielle gynäkologische Onkologie II. Urban & Schwarzenberg, München, S 173Google Scholar
  2. Flototto T, Djahansouzi S, Glaser M, Hanstein B, Niederacher D, Brumm C, Beckmann MW (2001) Hormones and hormone antagonists: mechanisms of action in carcinogenesis of endometrial and breast cancer. Horm Metab Res 33: 451–457PubMedCrossRefGoogle Scholar
  3. Friedberg T (2001) Cytochrome P450 polymorphisms as risk factors for steroid hormone-related cancers. Am J Pharmacogenomics to: 83–91Google Scholar
  4. Haid M (1981) Steroid antiemesis may be harmful. N Engl J Med 304: 1237PubMedGoogle Scholar
  5. Keshgegian AA, Cnaan A (1996) Estrogen receptor-negative, progesterone receptor-positive breast karzinoma: poor clinical outcome. Arch Pathol Lab Med 120: 970–973PubMedGoogle Scholar
  6. Liehr JG (2001) Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development. Hum Reprod Update 7: 273–281PubMedCrossRefGoogle Scholar
  7. Lippert TH, Seeger H, Mueck AO (2000) The impact of endogenous estradiol metabolites on carcinogenesis. Steroids 65: 357–369Google Scholar
  8. Lord RS, Bongiovanni B, Bralley JA (2002) Estrogen metabolites and the diet-cancer connection: rationale for asessing the ratio of urinary hydroxylated estrogen metabolites. Altern Med Rev 7: 112–129PubMedGoogle Scholar
  9. Massobrio M, Migliardi M, Cassoni P, Menzaghi C, Revelli A, Cenderelli G (1994) Steroid gradients across the cancerous breast: an index of altered steroid metabolism in breast cancer? J Steroid Biochem Mol Biol 51: 175–181PubMedCrossRefGoogle Scholar
  10. Mote PA, Bartow S, Tran N, Clarke CL (2002) Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat 72: 163–172PubMedCrossRefGoogle Scholar
  11. Nandi S, Guzma RC, Yang J (1995) Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci USA 92: 3650–3657PubMedCrossRefGoogle Scholar
  12. Pike MC, Spicer DV (2000) Hormonal contraception and chemoprevention of female cancers. Endocr Relat Cancer 7: 73–83PubMedCrossRefGoogle Scholar
  13. Powell CB, Mutch DG, Kao M-S, Wen-Yun J, Perry DL, Westphale E, Collins (1990) Dexamethasone used as an antiemetic in chemotherapy protocols inhibits natural cytotoxic ( NC) cell activity. Cancer 65: 466–472Google Scholar
  14. Raafat AM, Hofseth LJ, Haslam SZ (2001) Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model. Am J Obstet Gynecol 184: 340–349Google Scholar
  15. Rajkumar L, Guzman RC, Yang J, Thordarson G, Tala-mantes F, Nandi S (2001) Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci USA 98: 1175511759Google Scholar
  16. Schneider HP, Jackisch C (1998) Potential benefits of estrogens and progestogens on breast cancer. Int J Fertil Womens Med 43: 278–285Google Scholar
  17. Sherlock M, Hartmann WH (1962) Adrenal steroids and the pattern of metastases of breast cancer. J Am Med Assoc (JAMA) 181: 313–317CrossRefGoogle Scholar
  18. Tesarik J, Garrigosa L, Mendoza C (1999) Estradiol modulates breast cancer cell apoptosis: a novel nongenomic steroid action relevant to carcinogenesis. Steroids 64: 22–27PubMedCrossRefGoogle Scholar
  19. Von Georgi R, Münstedt K (2002) Ein multifaktorielles Modell zur Entstehung des Ovarialkarzinoms. Geburtsh Frauenheilkd 62: 1053–1059CrossRefGoogle Scholar
  20. WongYC,Xie B (2001) The role of androgens in mammary carcinogenesis. Ital J Anat Embryol 106 (2) [suppl 1]: u1–125Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • K. Münstedt
  • R. von Georgi

There are no affiliations available

Personalised recommendations